150 related articles for article (PubMed ID: 25256937)
1. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
Arce JC; Andersen AN; Fernández-Sánchez M; Visnova H; Bosch E; García-Velasco JA; Barri P; de Sutter P; Klein BM; Fauser BC
Fertil Steril; 2014 Dec; 102(6):1633-40.e5. PubMed ID: 25256937
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of ovarian stimulation with follitropin delta in a mixed regimen with HP-hMG: a real-world retrospective analysise.
Lim LJ; Kit AMF; Wong PS
Med J Malaysia; 2024 May; 79(3):275-280. PubMed ID: 38817059
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.
Lehert P; Kolibianakis EM; Venetis CA; Schertz J; Saunders H; Arriagada P; Copt S; Tarlatzis B
Reprod Biol Endocrinol; 2014 Feb; 12():17. PubMed ID: 24555766
[TBL] [Abstract][Full Text] [Related]
4. Prediction of ovarian response using the automated Elecsys anti-Müllerian hormone assay in gonadotrophin-releasing hormone antagonist cycles.
Bosch E; Labarta E; Zuzuarregui J; Iliodromiti S; Nelson SM
Reprod Biomed Online; 2023 Feb; 46(2):295-301. PubMed ID: 36522281
[TBL] [Abstract][Full Text] [Related]
5. Optimal antimüllerian hormone levels in oocyte donors: a national database analysis.
Sarkar P; Zalles L; Caswell W; Stratton M; Devine K; Harris BS; Romanski PA
Fertil Steril; 2024 Feb; 121(2):221-229. PubMed ID: 37949348
[TBL] [Abstract][Full Text] [Related]
6. Comparison of DNA damage in granulosa cells of women undergoing controlled ovarian stimulation in in vitro fertilization protocols with the recombinant human follicle-stimulating hormones Corneumon
Alcalá-Sánchez X; Cuapio-Padilla P; Salazar-López C; Rodríguez R; Teteltitla M; Bahena I; Betancourt M; Casas E; Casillas F; López A; Bonilla E
Arch Gynecol Obstet; 2024 May; 309(5):2107-2114. PubMed ID: 38441601
[TBL] [Abstract][Full Text] [Related]
7. Performance of anti-Müllerian hormone (AMH) levels measured by Beckman Coulter Access AMH assay to predict oocyte yield following controlled ovarian stimulation for in vitro fertilization.
Asada Y; Tsuiki M; Sonohara M; Fukunaga N; Hattori Y; Inoue D; Ito R; Hashiba Y
Reprod Med Biol; 2019 Jul; 18(3):273-277. PubMed ID: 31312106
[TBL] [Abstract][Full Text] [Related]
8. Response to: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.
Batista AR; Schwarze JE; Lispi M
Fertil Steril; 2024 Feb; 121(2):358. PubMed ID: 37734649
[No Abstract] [Full Text] [Related]
9. Antimüllerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction trial.
Zarek SM; Mitchell EM; Sjaarda LA; Mumford SL; Silver RM; Stanford JB; Galai N; Schliep KC; Radin RG; Plowden TC; DeCherney AH; Schisterman EF
Fertil Steril; 2016 Apr; 105(4):946-952.e2. PubMed ID: 26707905
[TBL] [Abstract][Full Text] [Related]
10. A retrospective analysis of ovarian response to gonadotropins after laparoscopic unilateral or bilateral salpingectomy for hydrosalpinges.
Mizusawa Y; Matsumoto Y; Kokeguchi S; Shiotani M
Health Sci Rep; 2020 Sep; 3(3):e187. PubMed ID: 32999942
[TBL] [Abstract][Full Text] [Related]
11. Reply of the Authors: Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
Nelson SM; Fauser BCJM; García-Velasco JA; Klein BM; Arce JC
Fertil Steril; 2024 Apr; 121(4):707. PubMed ID: 38266801
[No Abstract] [Full Text] [Related]
12. Low-serum antimüllerian hormone is linked with poor semen quality in infertile men screened for participation in a randomized controlled trial.
Holt R; Yahyavi SK; Wall-Gremstrup G; Jorsal MJ; Toft FB; Jørgensen N; Juul A; Blomberg Jensen M
Fertil Steril; 2024 Mar; ():. PubMed ID: 38522503
[TBL] [Abstract][Full Text] [Related]
13. Weekday vs. weekend oocyte retrievals: is there a difference?
Tarrash M; Sciandra C; Peyser A; Goldman RH; Mullin C
Hum Fertil (Camb); 2023 Dec; 26(5):1368-1373. PubMed ID: 37102565
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness Analysis.
Li H; He W; Lin H; Du A; Zhang X; Yang H; Qu S
Risk Manag Healthc Policy; 2024; 17():1387-1394. PubMed ID: 38828103
[TBL] [Abstract][Full Text] [Related]
15. Different anti-Műllerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes.
Ishii R; Tachibana N; Okawa R; Enomoto M; Asami M; Toriumi R; Hamada M; Horikawa M; Akiba Y; Taketani Y
Reprod Med Biol; 2019 Jul; 18(3):263-272. PubMed ID: 31312105
[TBL] [Abstract][Full Text] [Related]
16. Algorithm vs. clinical experience: controlled ovarian stimulations with follitropin-delta and individualised doses of follitropin-alpha/beta.
Gazzo I; Bovis F; Colia D; Sozzi F; Costa M; Anserini P; Massarotti C
Reprod Fertil; 2024 Feb; 5(1):. PubMed ID: 38330591
[TBL] [Abstract][Full Text] [Related]
17. High antimüllerian hormone level in oocyte donors: Is it a problem?
Ulker A; Hansen KR
Fertil Steril; 2024 Feb; 121(2):246-247. PubMed ID: 38042395
[No Abstract] [Full Text] [Related]
18. Reply of the Authors: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.
Witz CA; Doody KJ; Park JK; Daftary GS; Heiser PW
Fertil Steril; 2024 Feb; 121(2):359. PubMed ID: 37995797
[No Abstract] [Full Text] [Related]
19. Response to Individualized vs. conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
Longobardi S; D'Hooghe TM
Fertil Steril; 2024 Apr; 121(4):706. PubMed ID: 38147958
[No Abstract] [Full Text] [Related]
20. Correction to "Retrospective study of ovarian reaction and fertility in women with discordant antimullerian hormone and follicle-stimulating hormone/luteinizing hormone ratios during in vitro fertilization".
J Obstet Gynaecol Res; 2024 May; 50(5):924. PubMed ID: 38504485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
